SEB Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$502M Buy
434,130
+43,932
+11% +$51.8M 1.86% 11
2026
Q2
$468M Buy
390,198
+2,926
+0.8% +$2.99M 1.76% 10
2026
Q1
$356M Buy
+387,272
New +$393M 1.52% 10

Other funds holding LLY

SEB Asset Management's LLY Position: Q3 2026 in Review

SEB Asset Management increased its Eli Lilly (LLY) stake by 11% in Q3 2026, buying an estimated $51.8M and bringing the position to 434,130 shares worth $502M. The position accounts for 1.86% of the portfolio, ranked #11.

SEB Asset Management first reported a position in LLY in Q1 2026 and has held it in 3 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • SEB Asset Management held 434,130 shares of Eli Lilly worth $502M as of Q3 2026.
  • SEB Asset Management bought 43,932 Eli Lilly shares in Q3 2026, an estimated $51.8M.
  • Eli Lilly made up 1.86% of SEB Asset Management's portfolio in Q3 2026, its #11 holding.
  • SEB Asset Management first reported a position in Eli Lilly in Q1 2026 and has held it in 3 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.